Navigation Links
Elsevier announces publishing the Ocular Surface
Date:1/19/2012

New York, NY, January 19, 2012 Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce newly acquiring The Ocular Surface, a peer-reviewed journal focusing on the external eye and vision. As per January 2012 Elsevier will continue the publication of the quarterly journal.

The Ocular Surface delivers reviews of important work in laboratory science, clinical science, and clinical practice related to the external eye and vision, along with coverage of ongoing studies, patents pending, conference highlights, and more. The Ocular Surface has an Impact Factor of 3.103 and is ranked 7th out of 56 journals in the Ophthalmology category according to the 2011 Journal Citation Reports published by Thomson Reuters. The journal has remained in the top 10 ranking of Impact Factors for the last three years.

Gary N. Foulks, MD, Editor-in-Chief of The Ocular Surface said of the acquisition, "We are very pleased to start working with Elsevier. Together we will bring The Ocular Surface to a new level of excellence in serving our professional community."

"Elsevier is truly honored to publish The Ocular Surface. This premier journal represents innovative, high-quality content, and is an excellent addition to our leading ophthalmology journals program," Nancy Axelrod, Executive Publisher at Elsevier added.


'/>"/>
Contact: Rachael Zaleski
rachael.zaleski@elsevier.com
215-239-3658
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
2. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
3. Finalists announced in the Elsevier Grand Challenge
4. Winners announced in the Elsevier Grand Challenge
5. Elsevier announces 2008 journal impact factor highlights
6. Elseviers BrainNavigator research tool to launch new features at Neuroscience 2009 show
7. Elsevier pilots new research tool Reflect in its premier life science journal Cell
8. Gold Standard/Elsevier offers timely, reliable drug pricing data, including average wholesale price
9. Elsevier and Peking University Health Science Center develop new China online CME service
10. Elsevier pilots PeerChoice in Chemical Physics Letters
11. Elsevier announces the winner of the Ahmed Zewail prize in molecular sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... SAN JOSE, Calif. , Nov. 20, 2014 /PRNewswire/ ... a global leader in microcontroller (MCU) and touch technology ... digital temperature sensors with the widest V ... family delivers higher temperature accuracy and faster I 2 ... nonvolatile registers and serial EEPROM memory making them ideal ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
(Date:11/12/2014)... PALM BEACH GARDENS, Fla. , Nov. 12, 2014 ... management solutions, announced today that its U.are.U ® ... upscale retail bakery chain in Central Mexico ... solution in June 2014 to eliminate payroll issues caused ... Prior to installing the U.are.U fingerprint readers, Montparnasse ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... by which Helicobacter pylori , the only known cancer-causing ... The new study, in the journal Oncogene , reports ... pylori infection and stomach cancer, the second leading cause ... population is infected with H. pylori, a bacterium that can ...
... MADISON, WI, August 2nd, 2010 - Using little more than ... get a feel for soil water retention and field capacity, ... to engineering. The demonstration, developed by Adam Howard, Drs. ... was designed to illustrate concepts that can be difficult for ...
... research points to a genetic route to understanding and treating ... Penn State University, has identified an ancient gene family that ... the brain. "In healthy people, nerves do not fire ... us to focus on what really matters. Nerve cells ...
Cached Biology News:Cancer-causing bacterium targets tumor-suppressor protein 2Cancer-causing bacterium targets tumor-suppressor protein 3Students get a feel for soil-water relationships 2Epileptic seizures may be linked to an ancient gene family 2
(Date:12/19/2014)... 19, 2014 In contrast to traditional ... with various colors, Valoya uses proprietary LED technology to ... best possible uniformity which is critical in low proximity ... spectral accuracy throughout its lifetime which is up to ... , "The investment cost was clearly higher when ...
(Date:12/19/2014)... With only 2 weeks left of ... Sartorius Biohit products . The product specials include Buy ... Pipette Trade-in Program, and free pipette tips. , Sartorius ... the world. They are ideal for lab technicians performing ... ,     Full volume range of 0.1 uL to ...
(Date:12/19/2014)... , Dec. 18, 2014 Egenix, Inc. is pleased ... elected Chairman of the Board, to succeed Donald Fresne ... but will continue as a member of the Board.  In ... added to the company over almost twenty years, the Board ... Board of Directors has established a Search Committee to find ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... Ahn Brings ZyGEM Extensive Expertise in Developing and ... Commercializing Novel Clinical Products--, SOLANA BEACH, Calif., ... and innovative enzymatic solutions for DNA,extraction and detection and other ... Ph.D., as Chair of its newly,formed Clinical Advisory Board. Dr. ...
... Feb. 14 Biodel Inc. (Nasdaq:,BIOD) today reported financial ... net loss for the quarter was $11.0 million or ... Phase III clinical trials of,VIAject(TM) positions us to meet ... FDA by the end of 2008," stated Dr. Solomon ...
... 14 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... pharmaceutical and,medical device company, today announced unaudited ... fourth quarter and year ended,December 31, 2007. ... further,review and potential adjustment as described under ...
Cached Biology Technology:ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board 2ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board 3Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 2Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 3Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 4Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 5Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 6Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results 7Angiotech announces results for the fourth quarter ended December 31, 2007 2Angiotech announces results for the fourth quarter ended December 31, 2007 3Angiotech announces results for the fourth quarter ended December 31, 2007 4Angiotech announces results for the fourth quarter ended December 31, 2007 5Angiotech announces results for the fourth quarter ended December 31, 2007 6Angiotech announces results for the fourth quarter ended December 31, 2007 7Angiotech announces results for the fourth quarter ended December 31, 2007 8Angiotech announces results for the fourth quarter ended December 31, 2007 9Angiotech announces results for the fourth quarter ended December 31, 2007 10Angiotech announces results for the fourth quarter ended December 31, 2007 11Angiotech announces results for the fourth quarter ended December 31, 2007 12Angiotech announces results for the fourth quarter ended December 31, 2007 13Angiotech announces results for the fourth quarter ended December 31, 2007 14Angiotech announces results for the fourth quarter ended December 31, 2007 15Angiotech announces results for the fourth quarter ended December 31, 2007 16Angiotech announces results for the fourth quarter ended December 31, 2007 17Angiotech announces results for the fourth quarter ended December 31, 2007 18Angiotech announces results for the fourth quarter ended December 31, 2007 19Angiotech announces results for the fourth quarter ended December 31, 2007 20Angiotech announces results for the fourth quarter ended December 31, 2007 21Angiotech announces results for the fourth quarter ended December 31, 2007 22Angiotech announces results for the fourth quarter ended December 31, 2007 23Angiotech announces results for the fourth quarter ended December 31, 2007 24
... Goat anti-Human Alpha 1 ... sodium azide Goats were ... Alpha-1-acid glycoprotein in Freund's adjuvant. ... phase absorbed to ensure specificity. ...
Purified Mouse anti-Hu p120 Catenin (pT916) Storage Temperature: Refrigerate(2 to 8C)...
synphilin-1 (V-19)...
Anti-OSMR Monoclonal Antibody Research Focus: cytokine/growth factor Storage: 4C Shipping Temperature: 4C...
Biology Products: